Investment
Features
FeesSafety
Academy
More
Pluang+

Doseology to issue 75,268 shares to settle $13,548 consulting fees; director resigns.

Company Fundamentals
23 Sep 2026
PRNewsWire
View Source
Neutral
Doseology to issue 75,268 shares to settle $13,548 consulting fees; director resigns.

Doseology Sciences Inc. plans to issue 75,268 common shares at $0.18 each to settle $13,548.39 in accrued consulting fees to a former consultant. The share price is based on the closing price before the announcement, with completion expected around September 30, 2026. The shares will be subject to resale restrictions under Canadian securities laws. Additionally, director Daniel Vice resigned effective September 17, 2026. Doseology focuses on oral stimulant pouch products, a growing market segment.

Doseology's recent announcement is presented here with Consumer Staples sector data from Pluang as of Sep 24, 2026 05:21 WIB. For readers following Consumer Staples, of 51 priced US stocks tradable on Pluang, 23 rose and 28 fell today. Notable movers include SJM at USD 119.88 with a -2.50% change and a typical hold time of 73 days, DLTR at USD 115.11 with a +2.47% change and a typical hold time of 58 days, and RLX at USD 1.72 with a -2.00% change and a typical hold time of 32 days.

More News

NeoVolta Q4 revenue plunges but full-year sales jump 58% with new SK On battery deal

NeoVolta Q4 revenue plunges but full-year sales jump 58% with new SK On battery deal

NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...

Company Fundamentals
Bearish
3 hours ago
BlackBerry set to report Q3 earnings with strong QNX growth and cybersecurity gains.

BlackBerry set to report Q3 earnings with strong QNX growth and cybersecurity gains.

BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...

Company Fundamentals
Bullish
3 hours ago
Jaguar Health and Alkami lead sharp stock declines on September 23, with no clear causes for most drops.

Jaguar Health and Alkami lead sharp stock declines on September 23, with no clear causes for most drops.

On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...

Market News
Bearish
3 hours ago
WHLR jumps 191%, ARTL rises on obesity drug patent news, FSLY and IPDN also surge

WHLR jumps 191%, ARTL rises on obesity drug patent news, FSLY and IPDN also surge

Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...

Market News
Bullish
3 hours ago
Lindian Resources nears first rare earth concentrate production with 125,000 tonnes stockpiled at Kangankunde.

Lindian Resources nears first rare earth concentrate production with 125,000 tonnes stockpiled at Kangankunde.

Lindian Resources has stockpiled 125,000 tonnes of ore at its Kangankunde Rare Earths Project in Malawi, ahead of schedule for commissioning and first monazite concentrate production by the end of 2026. Mining operations are well established with the...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App